Seroconversion of Glutamic Acid Decarboxylase Antibodies in a Patient Initially Diagnosed as Having Type 2 Diabetes Mellitus

Internal Medicine - Japan
doi 10.2169/internalmedicine.44.299
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Japanese Society of Internal Medicine

Related search

Diabetes Mellitus and Ataxia With Anti-Glutamic Acid Decarboxylase Antibodies

Endocrine Abstracts
2016English

Absence of Glutamic Acid Decarboxylase Antibodies in Pima Indian Children With Diabetes Mellitus

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
1999English

Persisting Antibodies to Glutamic Acid Decarboxylase in Type 1 (Insulin-Dependent) Diabetes Mellitus Are Not Associated With Neuropathy

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
1993English

Antibodies to Glutamic Acid Decarboxylase Are Associated With HLA-DR Genotypes in Both Australians and Asians With Type 1 (Insulin-Dependent) Diabetes Mellitus

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
1992English

Cerebellar Ataxia With Anti–Glutamic Acid Decarboxylase Antibodies

Archives of Neurology
2001English

Clinical Characteristics of Anti-Glutamic Acid Decarboxylase Antibody-Positive Fulminant Type 1 Diabetes

Endocrine Journal
EndocrinologyMetabolismDiabetes
2019English

Effects of Anti-Glutamic Acid Decarboxylase Antibodies Associated With Neurological Diseases

Annals of Neurology
Neurology
2007English

Epilepsy and Cerebellar Ataxia Associated With Anti-Glutamic Acid Decarboxylase Antibodies

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
2007English

Detection of Autoantibodies Against Reactive Oxygen Species Modified Glutamic Acid Decarboxylase-65 in Type 1 Diabetes Associated Complications

BMC Immunology
Immunology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy